Preformulation Characterization of Griffithsin, a Biopharmaceutical Candidate for HIV Prevention

Griffithsin (GRFT) has shown potent anti-HIV activity, and it is being developed as a drug candidate for HIV prevention. Successful implementation requires thorough understanding of its preformulation characterization. In this work, preformulation assessments were conducted to characterize GRFT and...

Descripción completa

Detalles Bibliográficos
Autores principales: Kramzer, Lindsay F., Hamorsky, Krystal T., Graebing, Phillip W., Wang, Lin, Fuqua, Joshua L., Matoba, Nobuyuki, Lasnik, Amanda B., Moncla, Bernard J., Zhang, Junmei, Palmer, Kenneth E., Rohan, Lisa C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903873/
https://www.ncbi.nlm.nih.gov/pubmed/33625602
http://dx.doi.org/10.1208/s12249-021-01931-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903873/
https://www.ncbi.nlm.nih.gov/pubmed/33625602
http://dx.doi.org/10.1208/s12249-021-01931-0

Ejemplares similares